Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-operative mometasone irrigation versus mometasone nasal spray for chronic rhinosinusitis
ACTRN12612000866808Phase 4Recruiting
- Sponsor
- A/Prof Richard Harvey
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of mometasone in chronic rhinosinusitis (CRS) (2 arms), sponsored by A/Prof Richard Harvey. Primary endpoints: Symptom control and quality of life and Objective endoscopic and radiologic outcomes. Started Jan 2012; status: recruiting.
02
Drugs
mometasone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ACTRN12612000866808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000866808.